Plk1 overexpression induces chromosomal instability and suppresses tumor development

Area of Science:

• Cell Biology
• Cancer Biology
• Molecular Oncology

Background:

• Polo-like kinase 1 (Plk1) is frequently overexpressed in human tumors and considered a cancer target.
• The precise role of Plk1 in tumor development remains incompletely understood.
• Investigating Plk1's function is crucial for understanding cancer progression and developing targeted therapies.

Purpose of the Study:

• To elucidate the role of Plk1 overexpression in tumor development using a novel mouse model.
• To investigate the mechanistic basis of Plk1's effects on cell division and chromosome stability.
• To assess the impact of Plk1 overexpression on tumor formation and patient outcomes in breast cancer.

Main Methods:

• Development and utilization of an inducible knock-in mouse model for Plk1 overexpression.
• Analysis of chromosome segregation and cytokinesis in cells with Plk1 overexpression.
• Assessment of tumor development in Kras- and Her2-induced mammary gland tumor models.
• Correlation analysis of Plk1 expression with patient survival data in specific breast cancer subtypes.

Main Results:

• Plk1 overexpression leads to abnormal chromosome segregation and cytokinesis, resulting in polyploid cells with diminished proliferative capacity.
• Cytokinesis defects are linked to impaired loading of Cep55 and ESCRT complexes onto the abscission bridge, dependent on Plk1 kinase activity.
• In vivo, Plk1 overexpression inhibits the development of Kras- and Her2-driven mammary tumors, despite increased chromosome instability.
• Patient data reveals that Plk1 overexpression correlates with improved survival in certain breast cancer subtypes.

Conclusions:

• Plk1 overexpression exhibits tumor-suppressive properties by disrupting mitotic progression and cytokinesis, challenging its conventional oncogenic role.
• Despite its essential role in cancer cell proliferation, Plk1 overexpression can paradoxically hinder tumor development.
• These findings suggest a complex, context-dependent role for Plk1 in cancer, with potential implications for therapeutic strategies.